A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Clinical trial NCT02014116 · TERMINATED

Trial details

NCT number: NCT02014116
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis Melanoma Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms

Start date: 2013-11-26
Primary completion: 2017-04-07
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.